Vascular Solutions (VASC) Releases Earnings Results, Beats Expectations By $0.03 EPS

Vascular Solutions (VASC) reported quarterly earnings results on Monday, Jul-25-2016. The company said it had a profit of $0.33 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $0.30. The company posted revenue of $41.19 million in the period, compared to analysts expectations of $41.07 million. The company’s revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.29 EPS.

Many Wall Street Analysts have commented on Vascular Solutions. Vascular Solutions was Downgraded by Sidoti to ” Neutral” on Jul 12, 2016.

Vascular Solutions opened for trading at $42.77 and hit $43.56 on the upside on Wednesday, eventually ending the session at $42.89, with a gain of 0.70% or 0.3 points. The heightened volatility saw the trading volume jump to 95,108 shares. Company has a market cap of $745 M.

In a different news, on May 26, 2016, Howard Root (Chief Executive Officer) sold 34,418 shares at $39.05 per share price. According to the SEC, on May 16, 2016, Martin J Emerson (director) sold 20,000 shares at $37.93 per share price. On May 16, 2016, James Hennen (Sr. VP of Finance and CFO) sold 11,785 shares at $38.12 per share price, according to the Form-4 filing with the securities and exchange commission.

Vascular Solutions Inc. is a medical device company which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products which consist of the D-Stat Dry hemostat to control surface bleeding D-Stat Flowable for preventing bleeding in subcutaneous pockets Accumed wrist positioning splints and Vasc Band inflatable compression bands and Vein products which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.

Vascular Solutions

Leave a Reply

Vascular Solutions - Is it time to Sell?

Top Brokerage Firms are advising their investors on Vascular Solutions. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.